Biowatch

Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment

Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor microenvironment surrounding cancer...
FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients

FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients

Celltrion announced on October 7 that the U.S. Food and Drug Administration has approved an expanded pediatric indication for the intravenous...
Dongkook Pharmaceutical’s Madeca Pharmacia Expands to Hyundai Department Store’s ‘Khōde’

Dongkook Pharmaceutical’s Madeca Pharmacia Expands to Hyundai Department Store’s ‘Khōde’

Dongkook Pharmaceutical announced on October 7 that its derma repair brand, Madeca Pharmacia, has launched at Khōde, a...
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets

MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets

MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming...
FDA Approves Emcitate as First Treatment for Rare Genetic Disorder That Starves Brain of Thyroid Hormone

FDA Approves Emcitate as First Treatment for Rare Genetic Disorder That Starves Brain of Thyroid Hormone

Thyroid hormone is essential for infant brain development. But when the cellular "gateway" that transports the hormone...
New Parkinson’s Drug Cuts Daily “Off” Time by Nearly an Hour for Patients on Levodopa

New Parkinson’s Drug Cuts Daily “Off” Time by Nearly an Hour for Patients on Levodopa

You take your medication, but before long, stiffness returns and your hands begin to tremble.
Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026

Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026

Samsung Biologics has unveiled a process innovation case study demonstrating a reduction in biopharmaceutical...
Daewoong Pharmaceutical Enters Digital Therapeutics Market with Exclusive Deal for MCI Device 'Cogthera'

Daewoong Pharmaceutical Enters Digital Therapeutics Market with Exclusive Deal for MCI Device 'Cogthera'

Daewoong Pharmaceutical announced on the 22nd that it has signed an exclusive domestic sales and commercialization...
Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...